Inhibition of cell proliferation and antitumor activity of a novel organotin compound

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 20, Issue 4, 2001, Pages 333-342

  Syng Ai, Christine ^a   Baul, Tushar S Basu ^a   Chatterjee, Anupam ^a  

^a NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

Antineoplastic effect; Antitumor activity; Cell proliferation; GSH; Lymphoma; Organotin; Tin compound

Indexed keywords

GLUTATHIONE; ORGANOTIN COMPOUND;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; CLINICAL PROTOCOL; CONFERENCE PAPER; DEFENSE MECHANISM; DRUG EFFECT; MALE; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANIMALIA;

EID: 0035684558     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/jenvironpatholtoxicoloncol.v20.i4.100     Document Type: Conference Paper

References (47)

1. Organotin compounds induce aneuploidy in human peripheral lymphocytes in vitro
2. Genotoxic effects of triphenyltin acetate and triphenyltin hydroxide on mammalian cells in vitro and in vivo
3. Antagonizing effect of triphenyltin chloride on cytosine-1-β-D-arabinofuranoside potentiation of chromosome aberrations induced by mitomycin C
4. The chemotherapeutic properties of tin compounds
5. In vitro studies on tin - Dithiocarbamates
6. In vitro antiproliferation effects, toxicity profiles in vivo in mice and antitumor activity in tumor bearing mice of five diorganotin compounds
7. Antitumor active organotin compounds
8. Organotin implications in anticarcinogenesis. Effects of several organotins on tumor growth rate in mice
9. Investigations into the antitumor activity of organotin compounds. II. Diorganotin dihalide and dipseudohalide complexes
10. Investigations into the antitumor of diorganotin compounds. I. Diorganotin dihalides and di-pseudohalide complexes
11. Anti-tumor and toxic effects of silicon, germanium, tin and lead compounds
12. Possible predissociation of diorganotin dihalide complexes - Relationship between antitumor activity and structure
13. 4 = N-(2Pyridylmethylene)-4-toluidine]
14. Glutathione metabolism and its role in hepatotoxicity
15. Modifying effect of reduced glutathione on X-ray induced chromosome aberrations and cell cycle delay in muntjac lymphocytes in vitro
16. Influence of buthionine sulfoximine and reduced glutathione on arecoline induced chromosomal damage and sister chromatid exchange in mouse bone marrow cells in vivo
17. Modulation of mitomycin C-induced sister chromatid exchanges and cell cycle delay by buthionine sulfoximine and reduced glutathione in mouse bone marrow cells in vivo
18. Potentiation of bleomycin induced chromosome aberrations by the radioprotector-reduced glutathione
19. Modulation of the clastogenic activity of bleomycin by reduced-glutathione, glutathione-ester and buthionine sulfoximine
20. Modulation of the clastogenic activity of gamma irradiation in buthionine sulfoximine mediated glutathione depleted mammalian cells
21. Glutathione modifies the toxicity of triethyltin and trimethyltin in C6 glioma cells
22. Simple differential Giemsa staining of sister chromatids after treatment with photosensitive dyes and exposure to light and the mechanism of staining
23. Assay of glutathione, glutathione disulfide and glutathione mixed disulfides in biological samples
24. Translocation of intracellular glutathione to membrane-bound γ-glutamyl transpeptidase as a discrete step in the γ-glutamyl cycle; glutathionuria after inhibition of transpeptidase
25. Depletion of tumor versus normal tissue glutathione by buthionine sulfoximine
26. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro
27. Compartmentalized depletion of glutathione in cells treated with buthionine sulfoximine
28. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
29. Organotin compounds decrease in vitro survival, proliferation and differentiation of normal human B lymphocytes
30. Inhibition of mouse spleen cell activity by organotin compounds: Effect of attachment of a maltose residue to the organotin group
31. Immunotoxic organotins as possible model compounds in studying apoptosis and thymocyte differentiation
32. Organotin-induced apoptosis as observed in vitro is not relevant for induction of thymus atrophy at antiproliferative doses
33. Induction of apoptosis by organotin compounds in vitro: Neuronal protection with antisense oligonucleotides directed against stannin
34. Caspase involvement in the induction of apoptosis by the environmental toxicants tributyltin and triphenyltin
35. Apoptosis and necrosis: Intracellular levels of glutathione influence mode of cell death
36. Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line
37. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols
38. p53 puzzle and paradigm
39. Apoptosis and the cell cycle: The p53 connection
40. Cisplatin: A preclinic view
41. Anticancer activity of organotin compounds. 2. Interaction of diorganotin halides with nucleic bases and nucleosides: The synthesis of adenine, adenosine and 9-methyl-adenine adducts
42. Anticancer metal complexes and tumor targeting strategies
43. Glutathione localization in benign and malignant human breast lesions
44. Glutathione metabolism in patients with non small cell lung cancers
45. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells
46. Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation